GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Diagnos Inc (OTCPK:DGNOF) » Definitions » COGS-to-Revenue

Diagnos (Diagnos) COGS-to-Revenue : 4.82 (As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Diagnos COGS-to-Revenue?

Diagnos's Cost of Goods Sold for the three months ended in Dec. 2023 was $0.19 Mil. Its Revenue for the three months ended in Dec. 2023 was $0.04 Mil.

Diagnos's COGS to Revenue for the three months ended in Dec. 2023 was 4.82.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Diagnos's Gross Margin % for the three months ended in Dec. 2023 was -382.05%.


Diagnos COGS-to-Revenue Historical Data

The historical data trend for Diagnos's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diagnos COGS-to-Revenue Chart

Diagnos Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.33 2.42 2.31 1.95 1.63

Diagnos Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.31 2.86 5.06 8.63 4.82

Diagnos COGS-to-Revenue Calculation

Diagnos's COGS to Revenue for the fiscal year that ended in Mar. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0.579 / 0.355
=1.63

Diagnos's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0.188 / 0.039
=4.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Diagnos  (OTCPK:DGNOF) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Diagnos's Gross Margin % for the three months ended in Dec. 2023 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 0.188 / 0.039
=-382.05 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Diagnos COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Diagnos's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Diagnos (Diagnos) Business Description

Traded in Other Exchanges
Address
7005 Taschereau Boulevard, Suite 265, Brossard, Longueuil, QC, CAN, J4Z 1A7
Diagnos Inc is engaged in the provision of software-based interpretation services to assist health specialists in the detection of diabetic retinopathy. The company provides image analysis services through CARA (Computer Assisted Retinal Analysis). It operates in the business segment of Healthcare services. The company has a business presence in Canada, the United States, UAE, Saudi Arabia, Mexico, Costa Rica, and others. The company's key revenue is derived from Canada.

Diagnos (Diagnos) Headlines

From GuruFocus

DIAGNOS Announces Closing of Private Placement

By GlobeNewswire GlobeNewswire 02-11-2020

DIAGNOS Announces Final Closing of Private Placement

By GlobeNewswire GlobeNewswire 11-21-2018

DIAGNOS Announces Symbol Change on the OTCQB: DGNOD

By GlobeNewswire GlobeNewswire 05-08-2019